AU2002361390A8 - Anti-cd7 immunotoxin as fusion protein - Google Patents

Anti-cd7 immunotoxin as fusion protein

Info

Publication number: AU2002361390A8
Authority: AU; Australia
Prior art keywords: immunotoxin; fusion protein; fusion; protein
Prior art date: 2001-12-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002361390A

Other versions

AU2002361390A1 (en

Inventor

Matthias Peipp

Georg Heinrich Maximilian Fey

Martin Gramatzki

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Friedrich Alexander Universitaet Erlangen Nuernberg

Original Assignee

Friedrich Alexander Universitaet Erlangen Nuernberg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-14

Filing date

2002-12-11

Publication date

2003-06-30

2002-12-11 Application filed by Friedrich Alexander Universitaet Erlangen Nuernberg filed Critical Friedrich Alexander Universitaet Erlangen Nuernberg

2003-06-30 Publication of AU2002361390A1 publication Critical patent/AU2002361390A1/en

2003-06-30 Publication of AU2002361390A8 publication Critical patent/AU2002361390A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Hematology (AREA)
Oncology (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AU2002361390A 2001-12-14 2002-12-11 Anti-cd7 immunotoxin as fusion protein Abandoned AU2002361390A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US33942201P	2001-12-14	2001-12-14
US60/339,422		2001-12-14
PCT/EP2002/014064 WO2003051926A2 (en)	2001-12-14	2002-12-11	Anti-cd7 immunotoxin as fusion protein

Publications (2)

Publication Number	Publication Date
AU2002361390A1 AU2002361390A1 (en)	2003-06-30
AU2002361390A8 true AU2002361390A8 (en)	2003-06-30

Family

ID=23328933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002361390A Abandoned AU2002361390A1 (en)	2001-12-14	2002-12-11	Anti-cd7 immunotoxin as fusion protein

Country Status (2)

Country	Link
AU (1)	AU2002361390A1 (en)
WO (1)	WO2003051926A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1748050A1 (en) *	2005-07-28	2007-01-31	Rijksuniversiteit Groningen	Targeting-enhanced activation of galectins
US20070178103A1 (en) *	2006-01-30	2007-08-02	Fey Georg H	CD19-specific immunotoxin and treatment method
EP2010221B1 (en) *	2006-04-21	2012-02-29	mAB-Factory GmbH	Antibody-rnase-conjugate
WO2009064815A1 (en) *	2007-11-13	2009-05-22	The Scripps Research Institute	Production of cytotoxic antibody-toxin fusion in eukaryotic algae
EP3434346B1 (en)	2010-07-30	2020-09-02	Medimmune, LLC	Purified active polypeptides or immunoconjugates
CN102154355A (en) *	2011-01-06	2011-08-17	武汉大学	Recombinant immunotoxin CCL25-PE38 gene and preparation method as well as application thereof
CN102161998B (en) *	2011-01-14	2013-01-09	中国人民解放军军事医学科学院附属医院	Deoxyribonucleic acid (DNA) vaccine based on B7-1-PE40KDEL exotoxin fusion gene and application thereof
KR101521224B1 (en) *	2012-12-20	2015-05-19	한양대학교 산학협력단	Humanized single chain fragment antibody(scFv) carrier specific for T cell
LT3253865T (en)	2015-02-06	2022-11-10	National University Of Singapore	METHODS FOR ENHANCING THE EFFECTIVENESS OF THERAPEUTIC IMMUNE CELLS
US11390658B2 (en)	2016-06-06	2022-07-19	St. Jude Children's Research Hospital	Anti-CD7 chimeric antigen receptor and method of use thereof
EP3494132A4 (en) *	2016-08-03	2020-03-18	Washington University	GENETIC EDITING OF CAR-T CELLS FOR THE TREATMENT OF T-CELL MALIGNANCIES WITH CHIMERIC ANTIGEN RECEPTORS
CA3043752A1 (en)	2016-11-22	2018-05-31	National University Of Singapore	Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies
WO2018227132A1 (en) *	2017-06-09	2018-12-13	Rhode Island Council On Postsecondary Education	Linked and other ph-triggered compounds
US20190038733A1 (en)	2017-08-10	2019-02-07	National University Of Singapore	T cell receptor-deficient chimeric antigen receptor t-cells and methods of use thereof
JP7584299B2 (en)	2018-05-23	2024-11-15	ナショナルユニバーシティオブシンガポール	Blockade of CD2 surface expression and expression of chimeric antigen receptors for immunotherapy of T cell malignancies - Patent Application 20070123333
US20200071397A1 (en) *	2018-05-31	2020-03-05	Washington University	Chimeric antigen receptor t cells (car-t) for the treatment of cancer
WO2023155852A1 (en) *	2022-02-17	2023-08-24	上海优替济生生物医药有限公司	Modified immune effector cells and uses thereof
CN114560943B (en) *	2022-02-28	2022-12-16	先进生物(苏州)有限公司	CD7-CAR-T cell and preparation method and application thereof
WO2025012080A1 (en)	2023-07-13	2025-01-16	Christian-Albrechts-Universität Zu Kiel	Humanized anti-cd7 antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6372217B1 (en) *	1997-06-03	2002-04-16	Regents Of The University Of Minnesota	Methods for the treatment of CD7+ viral infection with TXU-7-PAP
CA2409746C (en) *	2000-05-18	2014-11-25	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Immunotoxin fusion proteins and means for expression thereof

2002
- 2002-12-11 AU AU2002361390A patent/AU2002361390A1/en not_active Abandoned
- 2002-12-11 WO PCT/EP2002/014064 patent/WO2003051926A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2003051926A2 (en)	2003-06-26
WO2003051926A3 (en)	2003-09-04
AU2002361390A1 (en)	2003-06-30

Publication	Publication Date	Title
AU2002361390A8 (en)	2003-06-30	Anti-cd7 immunotoxin as fusion protein
IL202255A0 (en)	2010-06-16	Binding domain-immunoglobulin fusion proteins
PL1687028T5 (en)	2016-05-31	Immunoglobulin preparations having increased stability
AU2002364586A8 (en)	2003-07-30	Albumin fusion proteins
AU2002364587A8 (en)	2003-07-30	Albumin fusion proteins
GB0117550D0 (en)	2001-09-12	Joint arrangement
EP1391209A4 (en)	2009-12-16	Protein formulations
EP1365022A4 (en)	2004-04-28	Adiponectin-associated protein
HUP0402496A3 (en)	2012-03-28	Growth hormone fusion protein
GB0108079D0 (en)	2001-05-23	Protein
AU2002357891A8 (en)	2003-07-24	Dtat fusion toxin
GB2382015B (en)	2005-03-02	Lawnmower
GB0103997D0 (en)	2001-04-04	Joint
GB0130721D0 (en)	2002-02-06	Protein
GB0106318D0 (en)	2001-05-02	Protein
GB2382320B (en)	2004-08-04	Welding aid
PL345633A1 (en)	2001-07-30	Joint
GB0129529D0 (en)	2002-01-30	Turning joint
GB0127758D0 (en)	2002-01-09	Turning joint
CA91523S (en)	2001-02-23	Necktie
GB0119593D0 (en)	2001-10-03	Thermoplastic welding
AU2001231918A1 (en)	2001-08-07	Scscntfr/nnt-1 fusion protein
GB0124637D0 (en)	2001-12-05	Protein
GB0119447D0 (en)	2001-10-03	Protein
GB0126304D0 (en)	2002-01-02	Protein

Legal Events

Date	Code	Title	Description
2004-09-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase